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Objective: To evaluate the feasibility, safety, and clinical outcomes of plug-assisted retrograde transvenous obliteration 
(PARTO) to treat gastric variceal hemorrhage in patients with portal hypertension.
Materials and Methods: From May 2012 to June 2014, 19 patients (11 men and 8 women, median age; 61, with history of 
gastric variceal hemorrhage; 17, active bleeding; 2) who underwent PARTO using a vascular plug and a gelfoam pledget 
were retrospectively analyzed. Clinical and laboratory data were examined to evaluate primary (technical and clinical 
success, complications) and secondary (worsening of esophageal varix [EV], change in liver function) end points. Median 
follow-up duration was 11 months, from 6.5 to 18 months. The Wilcoxon signed-rank test was used to compare laboratory 
data before and after the procedure.
Results: Technical success (complete occlusion of the efferent shunt and complete filling of gastric varix [GV] with a 
gelfoam slurry) was achieved in 18 of 19 (94.7%) patients. The embolic materials could not reach the GV in 1 patient who 
had endoscopic glue injection before our procedure. The clinical success rate (no recurrence of gastric variceal bleeding) 
was the same because the technically failed patient showed recurrent bleeding later. Acute complications included fever (n = 
2), fever and hypotension (n = 2; one diagnosed adrenal insufficiency), and transient microscopic hematuria (n = 3). Ten 
patients underwent follow-up endoscopy; all exhibited GV improvement, except 2 without endoscopic change. Five patients 
exhibited aggravated EV, and 2 of them had a bleeding event. Laboratory findings were significantly improved after PARTO.
Conclusion: PARTO is technically feasible, safe, and effective for gastric variceal hemorrhage in patients with portal 
hypertension. 
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INTRODUCTION
Gastric variceal bleeding is a common (25%), yet severe 
complication of portal hypertension (1). It is one of the 
leading causes of death in patients with liver cirrhosis (2, 3). 
Despite the advances in treatment over the last few decades, 
the mortality rate is still high with reported 5-year survival 
rate of 53.2% (4). The current guidelines recommend initial 
medical therapy followed by endoscopic glue injection 
for management of gastric varix (GV) (5, 6). Radiologic 
intervention includes transjugular intrahepatic portosystemic 
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gastric variceal bleeding underwent elective procedures. 
Two patients initially presented to the emergency room 
with active upper gastrointestinal bleeding that resulted 
in hemodynamic instability. Their initial vital signs were 
as follows: blood pressure 95/70 mm Hg with pulse 114/
minute for 1 patient, and blood pressure 96/48 mm Hg with 
pulse 111/minute for the other. After blood transfusion and 
terlipressin acetate (Glypressin, Ferring Korea, Seoul, Korea) 
administration, initial dose of 2 mg followed by additional 
1 mg every 4 hours during 3 days, emergent endoscopic 
glue injection was performed, but we could not control 
the bleeding because of the large amount of hematomas 
and food materials. A Sengstaken-Blakemore tube was 
applied instead, and PARTO was performed in an urgent/
emergent setting. Other 2 patients (10.5%) underwent 
endoscopic glue injection for GV 49 days or 4 days prior 
to our procedure, respectively. Only 1 patient with Child-
Pugh classification B showed hepatic encephalopathy, West 
Haven Criteria grade 1–2. Six patients had small amount of 
ascites before the procedure.
Preprocedural Evaluation
All patients underwent contrast-enhanced computed 
tomography imaging to evaluate the presence, as well as 
the size and the morphology of GV and GRS. Vascular plug 
of approximately 30% larger diameter than the GRS waist 
measured on CT images was selected. All patients had initial 
endoscopic evaluations. The presence and severity of GV and 
esophageal varix (EV) were assessed according to the rule 
proposed by The Japan Society for Portal Hypertension (15). 
Thirteen patients had F3 GV, of which, 2 had active gastric 
shunt (TIPS) and balloon-occluded retrograde transvenous 
obliteration (BRTO). In Asian countries, especially in South 
Korea and Japan, BRTO is performed more frequently than 
TIPS to treat gastric variceal hemorrhage, because BRTO 
is less invasive and reportedly improves hepatic function 
of the patients (7). One possible devastating complication 
of conventional BRTO is balloon rupture and subsequent 
systemic circulation of sclerosant. Reported incidence 
of this complication is 8.7% (8). Relatively common 
complications include hemolysis and hemoglobinuria. Rare, 
but previously reported complications include acute renal 
failure, pulmonary edema, and anaphylaxis to ethanolamine 
oleate (9-11). Dose limitation of sclerosing agents is 
another weak point of conventional BRTO. Finally, patients 
have to be placed on bed rest for at least 30 minutes to 3 
hours (12) or 4 to 24 hours before the balloon catheters are 
retrieved. To the best of our knowledge, only 2 studies from 
2 centers have been reported to evaluate the effectiveness 
of vascular plug and gelatin sponge-assisted retrograde 
transvenous obliteration (13, 14). Therefore, the purpose of 
our study was to evaluate the feasibility and safety of plug-
assisted retrograde transvenous obliteration (PARTO) for 
treating gastric variceal hemorrhage in patients with portal 
hypertension and its clinical outcomes. 
MATERIALS AND METHODS
Clinical Database and Patient Population
The Institutional Review Board at our hospital approved 
this retrospective study and waived the requirement of 
informed consent. We retrospectively reviewed the medical 
records of all 19 patients who underwent PARTO for gastric 
variceal hemorrhage between May 2012 and June 2014. 
All of them had liver cirrhosis and the history of remote or 
current gastric variceal bleeding on endoscopy. Only those 
with gastrorenal shunt (GRS) confirmed on pre-procedural 
CT scan were included. We excluded patients with high risk 
of esophageal variceal hemorrhage (nodular/tumorous form 
or previous history of bleeding) or intractable ascites. Total 
19 patients (11 men and 8 women, median age; 61, with 
history of gastric variceal hemorrhage; 17, active bleeding; 
2) who underwent PARTO using a vascular plug and a 
gelfoam pledget were included in the study population.
Patient Demographics
Table 1 summarized the patient characteristics of the 
study population. Seventeen patients with history of 
Table 1. Summary of Patient Characteristics
Patient Characteristics n = 19
Gender
Men 11 (58%)
Women 8 (42%)
Age, median (interquartile range) 61 (57.5, 69)
Liver cirrhosis, etiology
Hepatitis B 12 (63%)
Alcoholic 4 (21%)
Hepatitis C 1 (5%)
Non-B and non-C 2 (10%)
Child-Pugh classification
A 14 (74%)
B 4 (21%)
C 1 (5%)
Presence of hepatocelluar carcinoma 5 (26%)
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variceal bleeding. Five patients had F2 GV, and 1 patient 
was assessed as F1 with positive red color sign. Nine out 
of 19 patients had both GV and EV at initial endoscopic 
evaluation.
Procedure
All procedures were performed under conscious sedation 
using intravenous pethidine hydrochloride 25 mg (Pethidine, 
Je-il Pharmaceutical, Daegu, Korea), and local anesthesia 
at puncture site using lidocaine hydrochloride (Lidocaine, 
Je-il Pharmaceutical, Daegu, Korea). Right femoral vein 
was punctured under ultrasonography, and a 9 Fr TIPS 
sheath (Cook, Bloomington, IN, USA) was placed in the 
left renal vein or GRS. In cases where the catheter was 
not advanced to GRS due to vascular tortuosity, a 6–8 Fr 
guiding catheter (Brite Tip, Cordis, Miami Lakes, FL, USA) 
was used (n = 6, 31.6%). After negotiation, a 0.035-
inch guidewire (Terumo, Tokyo, Japan) was advanced to 
GRS adjacent to GV. A 10–22 mm Amplatzer vascular plug 
type 2 (AVP; St. Jude Medical, Inc., St. Paul, MN, USA) 
with a size compatible with the measured GRS diameter 
was deployed at the narrowest part, while we kept the 
guidewire next to the vascular plug. Finally, a 4 Fr angled-
tip catheter (Cobra; Terumo, Tokyo, Japan) was advanced 
to the GRS along the guidewire (Fig. 1). Contrast media 
was injected through the catheter 5 to 10 minutes after 
Fig. 1. 72-year-old female with GV and GRS. 
A. 9 Fr TIPS sheath is placed in left renal vein and tip is in orifice to GRS. Contrast injection reveals GRS with waist (black arrow). Small inferior 
phrenic collateral vein (black arrowhead) is also seen. B. Vascular plug (arrow) is placed at waist of GRS. With gelfoam slurry injection, inferior 
phrenic collateral vein is spontaneously occluded and GV is completely filled with gelfoam mixture. C. Pre-procedural CT scan shows GV (asterisk). 
D. Complete thrombosis (asterisk) of GV is reported on post-procedural CT scan 4 days after PARTO. CT = computed tomography, GRS = gastrorenal 
shunt, GV = gastric varix, PARTO = plug-assisted retrograde transvenous obliteration, TIPS = transjugular intrahepatic portosystemic shunt
A
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the plug deployment to confirm that the efferent shunt was 
completely blocked. In cases with minimal contrast leakage 
to the left renal vein, gradual gelfoam slurry embolization 
was attempted in turn until complete occlusion. For 
insufficient cases, supplementary embolization with 12 
mm x 0.035-inch platinum coil (Nester, Cook) was done 
through the 4 Fr catheter to ensure complete obstruction. 
Subsequently, embolization was performed using gelfoam 
slurry, the mixture of 1 mm3 gelatin sponges with half of 
contrast media and half of saline. It was injected carefully 
under fluoroscopic guidance until the left gastric vein or 
the posterior gastric vein was visualized. In cases with 
collateral veins, such as pericardiacophrenic vein, inferior 
phrenic vein, or intercostal vein, the gelfoam mixture was 
injected slowly and contrast media was injected in between 
to ensure that the collateral veins were occluded. We 
considered coil embolization for a large collateral vein that 
was not spontaneously occluded with gelfoam embolization. 
Technical success was defined as the successful placement 
of the vascular plug and complete filling of the GV with 
gelfoam pledgets on angiography. Clinical success was 
defined as no recurrent gastric variceal hemorrhage until 
the end of study period. Procedure time was calculated 
using the fluoroscopy time.
Follow-Up Evaluation
All patients were subjected to contrast-enhanced CT 
scanning within 1 month after the procedure to primarily 
evaluate GV obliteration, and also procedure-related 
complication such as hematoma or systemic thrombus, 
and advent of ectopic varices or ascites. Medical records 
were reviewed for acute complication, recurrent bleeding, 
and changes in liver function test after the procedure. 
Endoscopic follow-up was performed for 10 patients 
according to the discretion of the referring physicians, and 
changes in GV and EV were assessed. Median interval from 
the procedure to endoscopy was 3 months, from 4 days 
to 1 year. Follow-up laboratory tests were done within a 
week (from 3 days to 1 week, median 4 days) after the 
procedure to evaluate the changes in liver function of all 
patients. Median follow-up duration was 11 months, with 
interquartile range from 6.5 to 18 months.
Statistical Analysis
The Wilcoxon signed-rank test was used to compare 
laboratory data before and after PARTO. Statistical analysis 
was performed using SPSS version 20.0 (IBM Corp., Armonk, 
NY, USA). P values < 0.05 were considered as statistically 
significant.
RESULTS
Technical and clinical successes were achieved in 18 
of 19 patients (94.7%). Complete GV obliteration was 
confirmed using post-procedural CT scans in these 18 
patients. The median interval from the procedure to the CT 
scan was 4 days. Only partial thrombus of GV was observed 
in 2 patients after 3 days or 1 week from the procedure, 
but complete thrombosis and obliteration were verified in 
follow-up CT after 1 month. Even a large varix with waist 
diameter of 18 mm and maximal diameter of 27 mm was 
successfully obliterated by deploying a 22 mm vascular 
plug to the waist without the need for complementary coil 
embolization.
Plug-assisted retrograde transvenous obliteration failed 
in 1 patient due to incomplete filling of the GV with the 
gelfoam slurry (Fig. 2). The patient had impaired liver 
function (Child Pugh classification B) and concomitant 
hepatocellular carcinoma with a history of endoscopic 
glue injection 7 weeks before the procedure due to the 
gastric variceal hemorrhage. Pre-procedural CT scan taken 
before the endoscopic injection clearly delineated the 
GV and GRS. Although the posterior gastric vein and left 
gastric vein were sufficiently visualized during the gelfoam 
embolization, the embolic material did not completely fill 
the upper portion of gastric varix. The patient was admitted 
through our emergency department with hematemesis 4 
months after the PARTO. Recent gastric variceal hemorrhage 
was revealed in endoscopic evaluation and emergent 
endoscopic hemostasis was performed. One year later, 
the patient received liver transplantation. Therefore, the 
technical and clinical success rate for the PARTO was 94.7% 
(18/19 patients). 
Supplementary embolization with 12 mm x 0.035-inch 
platinum coil (Nester, Cook) was necessary in 3 patients 
(15.8%) to ensure complete occlusion of efferent GRS.
Five patients showed small collateral veins during gelfoam 
embolization. In regard to the collateral veins, 4 patients 
showed pericardiacophrenic veins, and 1 patient had an 
inferior phrenic vein collateral. These small collaterals 
could be occluded with the injection of gelfoam slurry, and 
additional embolization was not carried out in any patients.
Four of 19 (21.1%) patients had minimal contrast 
leakage caused by the rupture of small collaterals during 
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the gelfoam embolization. Nevertheless, filling of the 
GV continued slowly and embolization was technically 
successful. They did not experience clinical sign of 
hemorrhage or hemoglobin level drop after the procedure. 
On post-procedural CT scan, none showed retroperitoneal 
hematomas or fluid collection.
The median procedure time was 61 minutes, with 
interquartile range from 34.5 to 95.5 minutes. Shortening 
of procedure time from approximately 100 to 40 minutes 
throughout our study reflects the importance of the 
operator’s experiences in PARTO. In 1 patient with left-
sided inferior vena cava (IVC), the GRS could be approached 
directly through the left-sided IVC and the procedure time 
could be reduced (30 minutes).
Acute complications that occurred within 72 hours after 
the procedure were as follows: fever (n = 2), fever and 
hypotension (n = 2; one diagnosed adrenal insufficiency), 
and transient microscopic hematuria (n = 3). Two patients 
had fever (body temperature, 38°C) a few hours after the 
procedure. Though clinical focus of the fever was not clear 
in these patients, antipyretic drugs were administered to 
alleviate the symptom and their body temperatures were 
normalized on the next day. Two patients experienced 
fever and hypotension (body temperature 39°C, with blood 
Fig. 2. 58-year-old male with previous endoscopic histoacryl injection. 
A. Injected glue (asterisk) is demonstrated in upper portion of GV. B. Gelfoam embolization is performed sufficiently until left gastric vein (white 
arrow) is visualized. C. GV (asterisk) is delineated on pre-procedural CT scan, which is performed 1 week before endoscopic glue injection and 8 
weeks before PARTO procedure. Concomitant HCC (white arrow) is observed in left lateral lobe of liver, although it was not clearly visualized on 
this hepatic venous phase image. Post-ablation area (black arrow) is seen in right lobe of liver. D. Post-procedural CT scan reveals residual GV (black 
arrows) and previously injected endoscopic glue (black asterisk). Amount of ascites is increased after procedure. CT = computed tomography, GV = 
gastric varix, HCC = hepatocellular carcinoma, PARTO = plug-assisted retrograde transvenous obliteration
A
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pressure of 83/39 mm Hg, and 89/40 mm Hg, respectively), 
which were managed with fluid resuscitation. One patient 
recovered normal blood pressure within hours, but the blood 
pressure of the other patient fluctuated despite appropriate 
fluid therapy. In order to determine the cause of fluctuating 
blood pressure, low-dose adrenocorticotropic hormone test 
was conducted and adrenal insufficiency was confirmed in 
this patient. Oral hydrocortisone therapy with an initial 
dose of 30 mg per day (20 mg in morning and 10 mg in 
evening) was given and gradually tapered off for 3 months. 
The patient recovered completely after the completion 
of oral hydrocortisone therapy. Three patients (15.8%) 
manifested microscopic hematuria for 1–2 days after the 
PARTO procedure. Since hematuria resolved spontaneously 
in all these patients and post-procedural CT scans revealed 
no evidence of systemic thrombosis including renal vein 
thrombosis, the transient microscopic hematuria seemed to 
be idiopathic and clinically insignificant.
Post-procedural CT scans showed newly developed small 
amount of ascites in 5 of 18 (27.8%) successfully treated 
patients. Post-procedural CT scans of 6 patients who 
already had ascites before the procedure revealed increased 
amounts of ascites, but the increased volumes were not 
large enough to require drainage procedure. Thus, total 
11 out of 19 patients (58%) showed newly developed or 
increased amount of ascites. Three patients showed small 
ectopic varices including paraumbilical, rectal varices and 
inferior mesocaval shunt.
Among post-procedural endoscopy of 10 patients, GV 
completely resolved in 3 patients, and improved in 5 
patients. However, any endoscopic change was observed 
in 2 patients. Of these 2 patients, 1 patient was confirmed 
total thrombosis of GV on CT images conducted 4 days after 
our procedure, which was on the day that the endoscopy 
was performed. The other patient with technical failure, 
showed only partial thrombus in GV on the 1 month 
post-procedure follow-up CT scan. Diagnostic endoscopy 
performed 4 months later confirmed persistent GV and 
stigmata of gastric variceal bleeding. Endoscopic evaluation 
revealed newly developed EV in 1 of 18 patients who 
were successfully treated with PARTO. Four of 9 patients 
who already had EVs before the procedure experienced 
aggravation. As a result, total 5 out of 19 patients (26.3%) 
confirmed newly developed or aggravated EV by endoscopy. 
Two of these 4 patients had esophageal bleedings and 1 
patient died of massive hemorrhage 7 months after PARTO. 
The other patient was successfully treated with endoscopic 
variceal ligation (EVL). Remaining 3 patients underwent 
prophylactic EVLs, even though they did not experience 
esophageal variceal bleeding. 
Laboratory data from Wilcoxon signed-rank test revealed 
that international normalized ratio, total bilirubin and 
albumin levels were significantly improved after the 
procedure (p = 0.019, 0.000, and 0.004, respectively). 
During follow-up period, recurrent gastric variceal 
hemorrhage was not reported among 18 well-treated 
patients. Four patients died during follow-up period due to 
liver failure (n = 3, 2 within 2 months, 1 within 6 months 
after the PARTO) and EV bleeding which occurred 7 months 
after the procedure (n = 1).
DISCUSSION
In our study, PARTO showed a high technical success rate 
(18/19; 94.7%). There was no recurrent gastric variceal 
hemorrhage, and complete GV obliteration was confirmed 
by post-procedural CT scan in all technically succeeded 
patients. These results were consistent with the good 
technical and clinical success rate of PARTO reported in 
the previous 2 studies (13, 14). Although conventional 
BRTO is reportedly effective in controlling gastric variceal 
hemorrhage (1, 12), PARTO has several advantages over 
conventional BRTO. First, there is no risk of balloon rupture 
and subsequent pulmonary embolism, which can be fatal. 
Second, dose limitation of sclerosants is not an obstacle 
for PARTO, because gelfoam slurry is used instead. All 
patients with whom we had technically success showed 
complete obliteration of GV by single session. Prior studies 
on conventional BRTO reported high technical and clinical 
successes, but in some studies, repeated BRTO procedures 
were necessary for complete obliteration of large varies (9, 
16-18). Moreover, gelfoam is safer embolic material than 
ethanolamine oleate, which is recommended with 4000 
units of haptoglobin to prevent renal failure (19). Gelfoam 
is also a more familiar embolic material to interventional 
radiologists because it is used in various procedures 
throughout the body. Third, PARTO does not require a 
long post-procedural bed-rest with the indwelling balloon 
catheter and full monitoring. Even though balloon dwelling 
time varies greatly from 30 minutes to 24 hours among 
studies, cases with short indwelling time tend to show low 
obliteration rate, so long indwelling time is preferred in 
cases with large varices for complete obliteration (12, 20).
We used a guiding catheter in some patients to deploy a 
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plug in the narrowest portion of the GRS that is proximal 
to GV and apart from the left renal vein confluence. This 
could reduce the plug size, embolic volume, and procedure 
time. Considering the complication of systemic venous 
thrombosis after BRTO with reported incidence of 15% (21), 
we also anticipated that our method could reduce the risk 
of systemic venous thrombosis by preventing the plug from 
contacting left renal vein.
We used not only a vascular plug, but also additional 
coils for the complete obstruction of efferent flow in 3 
patients. To overcome the size limitation of PARTO, Lee 
et al. (22) recently introduced microcoils instead of a 
vascular plug to occlude the GRS efferent flow. The study 
used 2 microcatheters, 1 for GRS embolization with the 
gelfoam pledgets and the other for blocking the GRS. Both 
CARTO and our PARTO are effective for the obliteration of 
GV, but it takes longer to block GRS with microcoils than 
with a vascular plug (mean procedure time 2.8 hours vs. 
our median procedure time 61 minutes). By using both 
vascular plug and coil, we could overcome the weak points 
of both procedures. Varices with large GRS can be occluded 
completely in a shorter procedure time. For very small 
GRS, however, it could be hard to pass 4 Fr catheter beside 
deployed vascular plug even when a minimum sized plug 
is used. CARTO or conventional BRTO could be superior in 
such a small GRS. Further study is required to verify the 
suitability of each procedure for these small GRSs.
For the 1 failed case, previous histoacryl injection to 
GV is suspected to be a culprit. Exact cause is uncertain, 
because PARTO was successful for the other patient with 
prior endoscopic glue injection. The injected histoacryl 
could possibly have blocked the GRS pathway, and there 
is a risk of later development of another shunt, such as 
gastrocaval shunt. Further study is required to clarify the 
effect of prior histoacryl injection to the technical failure of 
PARTO. 
During the injection of gelfoam slurry, all collateral 
veins were occluded spontaneously. Because of the risk of 
gelfoam embolization to pulmonary arteries though the 
collateral veins, we gradually injected gelfoam pledgets 
under fluoroscopic guidance. Contrast media was injected 
in between to confirm the occlusion of these collaterals. 
Small amount of gelfoam could be circulated via these 
systemic venous connections, however, none of the patients 
had symptoms or signs of pulmonary embolism or systemic 
arterial embolism. 
Minimal leakage of contrast solution to retroperitoneum 
reported in 4 patients was probably due to the rupture 
of small collateral. Leakage of contrast solution is not a 
common complication of conventional BRTO, but 2 previous 
studies reported contrast extravasation in 1 of 43 patients 
and 3 of 56 patients (23, 24). Contrast leakage may be 
attributed to rupture of small collateral veins caused by 
pressurized injection of the gelfoam pledgets, although 
the actual pressure was low. Further study is needed to 
investigate whether PARTO using gelfoam pledgets is 
associated with increased incidence of rupture of small 
collateral veins.
The effectiveness of emergency BRTO for treating ruptured 
GV was reported previously, but repeated procedures were 
required in some of the patients (25, 26). One-session 
PARTO procedure was sufficient for treating both hemostasis 
and obliteration of GV in our 2 patients. A previous study 
indicated that 25% of patients experience re-bleeding 
after histoacryl sclerotherapy of active gastric variceal 
hemorrhage (27). Therefore, PARTO could be an alternative 
method for preventing recurrent hemorrhage in patients 
with active gastric variceal bleeding.
Although post-procedural adrenal insufficiency had not 
been previously reported as a complication of BRTO, this 
complication can be explained anatomically. Since the 
GRS joins left adrenal vein before it meets the left renal 
vein, it is possible to occlude left adrenal vein during the 
BRTO procedure. Nevertheless, this complication is rarely 
symptomatic, probably because the remaining contralateral 
adrenal gland compensates for the shortage of the 
hormone. Adrenal insufficiency is a possible complication 
of the PARTO in certain susceptible individuals, and this 
complication should be suspected and treated in patients 
with the consistent clinical symptoms.
Aggravation of EV is one of the drawbacks of BRTO and 
also of the PARTO. Combining TIPS with BRTO is currently 
tried. Some of the post-BRTO complications including 
aggravation of EV and ascites, were attributed to the 
increased portal flow. In terms of hemodynamics, TIPS 
could alleviate portal hypertension caused by BRTO. Saad et 
al. (28) reported protective value of combined TIPS against 
the development of hydrothorax/ascites. Protective effect 
against esophageal variceal worsening was not evaluated 
in this study, however, it might work theoretically. Further 
studies are required for determining factors for patient 
selection and the optimal timing for combined or sequential 
TIPS. 
Significant laboratory improvement after PARTO is 
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concordant with previous studies on the conventional BRTO 
(1, 29). We only evaluated short term change, i.e., within 1 
week, and this laboratory improvement may largely reflect 
the effect of hemostasis and conservative management. 
However, long term (3 years) hepatic function improvement 
after conventional BRTO is previously reported (30), and 
PARTO is expected to show similar favorable effect. 
In conclusion, PARTO is a technically feasible, safe, 
and effective treatment for gastric variceal hemorrhage in 
patients with portal hypertension.
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